PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016

被引：74

作者：

Banach, Maciej ^{[1
]}

Jankowski, Piotr ^{[2
]}

Jozwiak, Jacek ^{[3
]}

Cybulska, Barbara ^{[4
]}

Windak, Adam ^{[5
]}

Guzik, Tomasz ^{[6
]}

Mamcarf, Artur ^{[7
]}

Broncel, Marlena ^{[8
]}

Tomasik, Tomasz ^{[9
]}

Rysz, Jacek ^{[10
]}

Jankowska-Zdunczyk, Agnieszka ^{[11
]}

Hoffman, Piotr ^{[12
]}

Mastalerz-Migas, Agnieszka

机构：

[1] Med Univ Lodz, Chair Nephrol & Hypertens, Dept Hypertens, 113 Zeromskiego St, PL-90549 Lodz, Poland

[2] Jagiellonian Univ, Coll Med, Inst Cardiol, Dept Cardiol Intervent Electrocardiol & Hypertens, Krakow, Poland

[3] Czestochowa Tech Univ, Inst Hlth & Nutr Sci, Czestochowa, Poland

[4] Natl Food & Nutr Inst, Warsaw, Poland

[5] Jagiellonian Univ, Coll Med, Chair Internal Med & Gerontol, Dept Family Med, Krakow, Poland

[6] Jagiellonian Univ, Coll Med, Dept Internal Dis & Rural Med, Krakow, Poland

[7] Med Univ Warsaw, Fac Med 2, Dept Internal Dis & Cardiol 3, Warsaw, Poland

[8] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lodz, Poland

[9] Jagiellonian Univ, Coll Med, Chair Internal Med & Gerontol, Dept Family Med, Krakow, Poland

[10] Med Univ Lodz, Chair Nephrol & Hypertens, Dept Nephrol Hypertens & Family Med, Lodz, Poland

[11] Inst Cardiol, Dept Congenital Cardiac Defects, Warsaw, Poland

[12] Wroclaw Med Univ, Chair & Dept Family Med, Wroclaw, Poland

来源：

ARCHIVES OF MEDICAL SCIENCE | 2017年 / 13卷 / 01期

关键词：

DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; TYPE-2; DIABETES-MELLITUS; CHRONIC KIDNEY-DISEASE; RESIDUAL CARDIOVASCULAR RISK; ASSOCIATION EXPERT PANEL; LOWERING LDL CHOLESTEROL; STATIN THERAPY; PRIMARY PREVENTION; POSITION PAPER;

D O I：

10.5114/aoms.2017.64712

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1 / 45

页数：45

共 166 条

[1] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].

Abifadel, M ;

Varret, M ;

Rabès, JP ;

Allard, D ;

Ouguerram, K ;

Devillers, M ;

Cruaud, C ;

Benjannet, S ;

Wickham, L ;

Erlich, D ;

Derré, A ;

Villéger, L ;

Farnier, M ;

Beucler, I ;

Bruckert, E ;

Chambaz, J ;

Chanu, B ;

Lecerf, JM ;

Luc, G ;

Moulin, P ;

Weissenbach, J ;

Prat, A ;

Krempf, M ;

Junien, C ;

Seidah, NG ;

Boileau, C .

NATURE GENETICS, 2003, 34 (02) :154-156

[2] Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention [J].

Amarenco, Pierre ;

Labreuche, Julien .

LANCET NEUROLOGY, 2009, 8 (05) :453-463

[3]

[Anonymous], 1992, Arch Intern Med, V152, P1399

[4]

[Anonymous], POL ARCH MED WEWN

[5] Lipid-lowering for peripheral arterial disease of the lower limb [J].

Aung, P. P. ;

Maxwell, H. G. ;

Jepson, R. G. ;

Price, J. F. ;

Leng, G. C. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04)

[6] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].

Catapano, Alberico L. ;

Graham, Ian ;

De Backer, Guy ;

Wiklund, Olov ;

Chapman, M. John ;

Drexel, Heinz ;

Hoes, Arno W. ;

Jennings, Catriona S. ;

Landmesser, Ulf ;

Pedersen, Terje R. ;

Reiner, Zeljko ;

Riccardi, Gabriele ;

Taskinen, Marja-Riita ;

Tokgozoglu, Lale ;

Verschuren, W. M. Monique ;

Vlachopoulos, Charalambos ;

Wood, David A. ;

Luis Zamorano, Jose .

ATHEROSCLEROSIS, 2016, 253 :281-344

[7] Pregnancy in women suffering from familial hypercholesterolemia: a harmful period for both mother and newborn? [J].

Avis, Hans J. ;

Hutten, Barbara A. ;

Twickler, Marcel Th. B. ;

Kastelein, John J. P. ;

van der Post, Joris A. M. ;

Stalenhoef, Anton F. ;

Vissers, Maud N. .

CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (06) :484-490

[8] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial [J].

Baigent, Colin ;

Landray, Martin J. ;

Reith, Christina ;

Emberson, Jonathan ;

Wheeler, David C. ;

Tomson, Charles ;

Wanner, Christoph ;

Krane, Vera ;

Cass, Alan ;

Craig, Jonathan ;

Neal, Bruce ;

Jiang, Lixin ;

Hooi, Lai Seong ;

Levin, Adeera ;

Agodoa, Lawrence ;

Gaziano, Mike ;

Kasiske, Bertram ;

Walker, Robert ;

Massy, Ziad A. ;

Feldt-Rasmussen, Bo ;

Krairittichai, Udom ;

Ophascharoensuk, Vuddidhej ;

Fellstrom, Bengt ;

Holdaas, Hallvard ;

Tesar, Vladimir ;

Wiecek, Andrzej ;

Grobbee, Diederick ;

de Zeeuw, Dick ;

Gronhagen-Riska, Carola ;

Dasgupta, Tanaji ;

Lewis, David ;

Herrington, William ;

Mafham, Marion ;

Majoni, William ;

Wallendszus, Karl ;

Grimm, Richard ;

Pedersen, Terje ;

Tobert, Jonathan ;

Armitage, Jane ;

Baxter, Alex ;

Bray, Christopher ;

Chen, Yiping ;

Chen, Zhengming ;

Hill, Michael ;

Knott, Carol ;

Parish, Sarah ;

Simpson, David ;

Sleight, Peter ;

Young, Alan ;

Collins, Rory .

LANCET, 2011, 377 (9784) :2181-2192

[9] Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER study) [J].

Ballantyne, Christie M. ;

Weiss, Robert ;

Moccetti, Tiziano ;

Vogt, Anja ;

Eber, Bernd ;

Sosef, Froukje ;

Duffield, Emma .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (05) :673-680

[10]

Banach M., 2017, Pharmacol Ther, V170, P181, DOI DOI 10.1016/J.PHARMTHERA.2016.11.001

← 1 2 3 4 5 6 7 8 9 10 →